Literature DB >> 26623092

High risk percutaneous coronary interventions-significance of left ventricular assist device for clinical practice.

Vladimir Ganyukov1, Roman Tarasov1.   

Abstract

Year:  2015        PMID： 26623092      PMCID： PMC4635266          DOI： 10.3978/j.issn.2072-1439.2015.10.57

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.

Authors:  Mauricio G Cohen; Ray Matthews; Brij Maini; Simon Dixon; George Vetrovec; David Wohns; Igor Palacios; Jeffrey Popma; E Magnus Ohman; Theodore Schreiber; William W O'Neill
Journal:  Am Heart J       Date:  2015-08-15       Impact factor: 4.749

Review 2.  Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support.

Authors:  Srihari S Naidu
Journal:  Circulation       Date:  2011-02-08       Impact factor: 29.690

3.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiología Intervencionista; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.

Authors:  Charanjit S Rihal; Srihari S Naidu; Michael M Givertz; Wilson Y Szeto; James A Burke; Navin K Kapur; Morton Kern; Kirk N Garratt; James A Goldstein; Vivian Dimas; Thomas Tu
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

4.  A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.

Authors:  William W O'Neill; Neal S Kleiman; Jeffrey Moses; Jose P S Henriques; Simon Dixon; Joseph Massaro; Igor Palacios; Brijeshwar Maini; Suresh Mulukutla; Vladimír Dzavík; Jeffrey Popma; Pamela S Douglas; Magnus Ohman
Journal:  Circulation       Date:  2012-08-30       Impact factor: 29.690

5.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

6.  Successful antegrade revascularization by the innovation of composite core dual coil in a three-vessel total occlusive disease for cardiac arrest patient using extracorporeal membrane oxygenation.

Authors:  Alfredo R Galassi; Vladimir Ganyukov; Salvatore Davide Tomasello; Boris Haes; Barbarash Leonid
Journal:  Eur Heart J       Date:  2014-02-26       Impact factor: 29.983

7.  Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.

Authors:  Marjo Hordijk-Trion; Mattie Lenzen; William Wijns; Peter de Jaegere; Maarten L Simoons; Wilma J M Scholte op Reimer; Michel E Bertrand; Nestor Mercado; Eric Boersma
Journal:  Eur Heart J       Date:  2006-01-19       Impact factor: 29.983

8.  Outcome of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: A single-center experience.

Authors:  Salvatore Davide Tomasello; Marouane Boukhris; Vladimir Ganyukov; Alfredo R Galassi; Dmitri Shukevich; Boris Haes; Nikita Kochergin; Roman Tarasov; Vadim Popov; Leonid Barbarash
Journal:  Heart Lung       Date:  2015-04-23       Impact factor: 2.210

9.  Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.

Authors:  Paul A Heidenreich; Nancy M Albert; Larry A Allen; David A Bluemke; Javed Butler; Gregg C Fonarow; John S Ikonomidis; Olga Khavjou; Marvin A Konstam; Thomas M Maddox; Graham Nichol; Michael Pham; Ileana L Piña; Justin G Trogdon
Journal:  Circ Heart Fail       Date:  2013-04-24       Impact factor: 8.790

10.  The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative.

Authors:  Mauricio G Cohen; Steven J Filby; Matthew T Roe; Anita Y Chen; Venu Menon; George A Stouffer; W Brian Gibler; Sidney C Smith; Charles V Pollack; Eric D Peterson; E Magnus Ohman
Journal:  Am Heart J       Date:  2009-08       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.